this may tell you why....BOA mention COH on the 23-9-13 price should be higher than where it currently is...
Cochlear (ASX:COH)‘s stock had its “underperform” rating restated by stock analysts at Bank of America Corp. in a report issued on Monday, AnalystRatingsNetwork.com reports.
Shares of Cochlear (ASX:COH) traded down 0.24% on Monday, hitting A$59.250. 235,026 shares of the company’s stock traded hands. Cochlear has a one year low of A$52.710 and a one year high of A$82.870. The stock has a 50-day moving average of A$58.70 and a 200-day moving average of A$62.59. The company has a market cap of A$3.372 billion and a P/E ratio of 25.56.
Several other analysts have also recently commented on the stock. Analysts at Credit Suisse reiterated an “underperform” rating on shares of Cochlear (ASX:COH) in a research note to investors on Wednesday, September 18th. Finally, analysts at CIMB reiterated an “underperform” rating on shares of Cochlear (ASX:COH) in a research note to investors on Sunday, August 25th.
Four equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. Cochlear currently has a consensus rating of “Hold” and a consensus target price of A$70.54 ($66.55).
COH Price at posting:
$60.68 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)